Focusing on key melanoma drivers63, we selected the top target pairs among the strongest ISLE-predicted cSLi between them—AKT1 and PIK3CA, and BCL2L1 and IGF1R (Table 1, Supplementary Data 9). This evidence concerns the gene BCL2L1 and melanoma.